Keros Therapeutics (KROS)
(Delayed Data from NSDQ)
$49.57 USD
-1.25 (-2.46%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $49.63 +0.06 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For KROS
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2023 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2023 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results